These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 33614688)

  • 1. Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US.
    Marić I; Oskotsky T; Kosti I; Le B; Wong RJ; Shaw GM; Sirota M; Stevenson DK
    Front Med (Lausanne); 2021; 8():639804. PubMed ID: 33614688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study.
    Umakanthan S; Senthil S; John S; Madhavan MK; Das J; Patil S; Rameshwaram R; Cintham A; Subramaniam V; Yogi M; Bansal A; Achutham S; Shekar C; Murthy V; Selvaraj R
    Front Pharmacol; 2022; 13():742273. PubMed ID: 35865966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study.
    Fan Y; Guo T; Yan F; Gong M; Zhang XA; Li C; He T; Luo H; Zhang L; Chen M; Wu X; Wang H; Deng KQ; Bai J; Cai L; Lu Z
    Front Med (Lausanne); 2020; 7():584870. PubMed ID: 33330541
    [No Abstract]   [Full Text] [Related]  

  • 4. Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19.
    Gupta A; Madhavan MV; Poterucha TJ; DeFilippis EM; Hennessey JA; Redfors B; Eckhardt C; Bikdeli B; Platt J; Nalbandian A; Elias P; Cummings MJ; Nouri SN; Lawlor M; Ranard LS; Li J; Boyle C; Givens R; Brodie D; Krumholz HM; Stone GW; Sethi SS; Burkhoff D; Uriel N; Schwartz A; Leon MB; Kirtane AJ; Wan EY; Parikh SA
    Res Sq; 2020 Aug; ():. PubMed ID: 32818209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients.
    Peymani P; Dehesh T; Aligolighasemabadi F; Sadeghdoust M; Kotfis K; Ahmadi M; Mehrbod P; Iranpour P; Dastghaib S; Nasimian A; Ravandi A; Kidane B; Ahmed N; Sharma P; Shojaei S; Bagheri Lankarani K; Madej A; Rezaei N; Madrakian T; Los MJ; Labouta HI; Mokarram P; Ghavami S
    Transl Med Commun; 2021; 6(1):3. PubMed ID: 33521322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19.
    Liu C; Yan W; Shi J; Wang S; Peng A; Chen Y; Huang K
    Front Nutr; 2022; 9():927092. PubMed ID: 35811982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
    Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
    JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Evidence of Statins' Protective Role against COVID-19 Hallmarks.
    Fiore D; Proto MC; Franceschelli S; Pascale M; Bifulco M; Gazzerro P
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
    PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.
    Parit R; Jayavel S
    Eur J Pharmacol; 2021 Apr; 896():173899. PubMed ID: 33508281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.
    Sperry MM; Oskotsky T; MariÄ I; Kaushal S; Takeda T; Horvath V; Powers RK; Rodas M; Furlong B; Soong M; Prabhala P; Goyal G; Carlson KE; Wong RJ; Kosti I; Le BL; Logue J; Hammond H; Frieman M; Stevenson DK; Ingber DE; Sirota M; Novak R
    medRxiv; 2022 Jul; ():. PubMed ID: 35441166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19.
    Bae DJ; Tehrani DM; Rabadia SV; Frost M; Parikh RV; Calfon-Press M; Aksoy O; Umar S; Ardehali R; Rabbani A; Bokhoor P; Nsair A; Currier J; Tobis J; Fonarow GC; Dave R; Rafique AM
    Am J Cardiol; 2020 Oct; 132():150-157. PubMed ID: 32819683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
    Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
    Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
    Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
    FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients.
    Daniels LB; Sitapati AM; Zhang J; Zou J; Bui QM; Ren J; Longhurst CA; Criqui MH; Messer K
    Am J Cardiol; 2020 Dec; 136():149-155. PubMed ID: 32946859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study.
    Kouhpeikar H; Khosaravizade Tabasi H; Khazir Z; Naghipour A; Mohammadi Moghadam H; Forouzanfar H; Abbasifard M; Kirichenko TV; Reiner Ž; Banach M; Sahebkar A
    Front Cardiovasc Med; 2022; 9():820260. PubMed ID: 35282379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins in COVID-19 Therapy.
    Olszewska-Parasiewicz J; Szarpak Ł; Rogula S; Gąsecka A; Szymańska U; Kwiatkowska M; Jaguszewski MJ; Sierpiński R; Zaczyński A; Wierzba W; Kosior DA
    Life (Basel); 2021 Jun; 11(6):. PubMed ID: 34208435
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.